Meet Our Founder: Daphné Truan, PhD

Daphné Truan is a scientific advisor specializing in protein design, biologics and vaccines discovery, and R&D portfolio strategy. With over a decade of experience at the interface of science, business development, and operations, she helps organizations accelerate the development of biologics and vaccines, from target identification to preclinical candidate selection, while aligning scientific innovation with commercial and operational priorities.

Drawing on her background in physics (Ing Dipl Phys & MSc EPFL) and structural biology (PhD ETHZ), Daphné combines deep scientific expertise with a strong focus on operational excellence and market-driven strategy. She has built and led intercontinental teams in large pharma environments, implemented bioinformatics platforms, launched cross-functional taskforces applying AI/ML to de novo antibody design and developability assessments, and guided data and portfolio strategies for protein-based therapeutics and vaccines discovery workflows.

Her strengths lie in translating complex scientific challenges into clear, actionable strategies that help teams select the right targets, prioritize pipelines, design and optimize proteins, and integrate predictive tools to improve decision-making and reduce attrition. Additionally, she advises clients on business development activities including competitive landscape analysis, pricing strategies, stakeholder engagement, and digital presence development to maximize visibility and market impact.

If your organization is looking for expertise that bridges scientific depth with strategic perspective, Daphné offers tailored consulting that aligns science, data, and business outcomes for sustainable growth and innovation.